Concomitant Use of Medications With Anticholinergic Properties and Acetylcholinesterase Inhibitors: Impact on Cognitive and Physical Functioning in Alzheimer Disease-Reference-Cited by-同舟云学术

Concomitant Use of Medications With Anticholinergic Properties and Acetylcholinesterase Inhibitors: Impact on Cognitive and Physical Functioning in Alzheimer Disease

Published:2007-04 Issue:4 Volume:15 Page:357-359
ISSN:1064-7481
Container-title:The American Journal of Geriatric Psychiatry
language:en
Short-container-title:The American Journal of Geriatric Psychiatry

Author:

Bottiggi Kara A.,Salazar Juan C.,Yu Lei,Caban-Holt Allison M.,Ryan Melody,Schmitt Frederick A.

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Geriatrics and Gerontology

Reference3 articles.

1. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer's disease;Lu;Am J Geriatr Psychiatry,2003

2. ‘Mini-mental state.’ A practical method for grading the cognitive state of patients for the clinician;Folstein;J Psychiatr Res,1975

3. Assessment of older people: self-maintaining and instrumental activities of daily living;Lawton;Gerontologist,1969

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticholinergic burden for prediction of cognitive decline or neuropsychiatric symptoms in older adults with mild cognitive impairment or dementia;Cochrane Database of Systematic Reviews;2022-08-22

2. Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer’s Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression;The Journal of Prevention of Alzheimer's Disease;2022

3. Anticholinergic Drugs in Geriatric Psychopharmacology;Frontiers in Neuroscience;2019-12-06

4. INtervention for Cognitive Reserve Enhancement in delaying the onset of Alzheimer’s Symptomatic Expression (INCREASE), a randomized controlled trial: rationale, study design, and protocol;Trials;2019-12

5. Routine deprescribing of chronic medications to combat polypharmacy;Therapeutic Advances in Drug Safety;2015-11-03